Ambu A/S (OTCMKTS:AMBBY - Get Free Report) announced its earnings results on Wednesday. The company reported $0.10 earnings per share for the quarter, Zacks reports. Ambu A/S had a return on equity of 5.67% and a net margin of 5.69%.
Ambu A/S Stock Performance
Shares of AMBBY stock traded up $0.29 during trading hours on Friday, reaching $15.65. 595 shares of the company's stock were exchanged, compared to its average volume of 477. Ambu A/S has a fifty-two week low of $13.02 and a fifty-two week high of $22.65. The company has a quick ratio of 1.47, a current ratio of 2.60 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $3.68 billion, a P/E ratio of 92.06 and a beta of 1.45. The business has a fifty day moving average price of $17.10 and a 200-day moving average price of $17.03.
Ambu A/S Company Profile
(
Get Free Report)
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Further Reading
Before you consider Ambu A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambu A/S wasn't on the list.
While Ambu A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
